Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. GB Sciences, Inc.
  6. Company
    GBLX   US3615441090

GB SCIENCES, INC.

(GBLX)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Logo GB Sciences, Inc.
GB Sciences, Inc. is a phytomedical research and biopharmaceutical drug development company. The Company is engaged in the research and development of plant-based medicines and plans to produce plant-inspired, complex therapeutic mixtures based on its portfolio of intellectual property. It offers artificial intelligence (AI) accelerated drug discovery platform, PhAROS, Phytomedical Analytics for Research Optimization at Scale. The PhAROS platform is a science gateway and virtual research environment for drug discovery. Through its subsidiary, GBS Global Biopharma, Inc., the company is engaged in the research and development of plant-based medicines, primarily cannabinoid medicines, with virtual operations in North America and Europe. The Company's list of subsidiaries includes GBS Global Biopharma, Inc., ECRX, Inc., The PhAROS Institute, LLC, GB Sciences Texas, LLC, GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC and GB Sciences Nopah, LLC.

Number of employees : 30 people.
Sales per Business
20202021Delta
Medical-grade Cannabis3.12100%---
USD in Million
Sales per region
20202021Delta
United States3.12100%---
USD in Million
Managers
Name Title Age Since
John Claybron Poss Chairman & Chief Executive Officer 72 2021
Andrea Small-Howard, Dr. President, Director & Chief Science Officer 51 2021
Zach Swarts Chief Financial Officer & Treasurer 32 -
Edmond A. DeFrank Independent Director 53 2019
Gary R. Henrie Secretary - 2021
Darin Carpenter Executive VP-Operations & General Manager - 2019
Monica Poss Vice President-Corporate Planning - 2018
Liz Bianco Publicity Director - -
Members of the board
Name Title Age Since
John Claybron Poss Chairman & Chief Executive Officer 72 2021
Andrea Small-Howard, Dr. President, Director & Chief Science Officer 51 2021
Edmond A. DeFrank Independent Director 53 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 317,429,078 274,631,518 86.5% 0 0.0% 86.5%
Shareholders
NameEquities%
Robert Moody 18,002,500 5.67%
Lawrence Burton Ordower 13,150,560 4.14%
David J. Ruggieri 11,303,500 3.56%
John Claybron Poss 225,000 0.071%
Andrea Small-Howard 116,000 0.037%
Columbia Management Investment Advisers LLC 50,000 0.016%
AlphaMark Advisors LLC 525 0.0002%
Weston Capital Management, Inc. 20 0.0000%
Gary R. Henrie 0 -
Edmond A. DeFrank 0 -
Company contact information
GB Sciences, Inc.
3550 West Teco Avenue
Las Vegas, NV 89118

Phone : +1.866.721.0297
Web : http://www.gbsciences.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of GB Sciences, Inc.
Sector Other Biotechnology & Medical Research
Connections : GB Sciences, Inc.